The St. Jude Medical Infinity™ Deep Brain Stimulation (DBS) system with directional lead technology is designed to help patients with Parkinson’s disease or essential tremor gain control of their ...
Boston Scientific (($BSX)) announced an update on their ongoing clinical study. Study Overview: The Vercise DBS Registry, ...
NEW ORLEANS — A new multiple-source system for deep-brain stimulation (DBS) in patients with Parkinson's disease proved effective in the randomized, double-blind INTREPID trial, meeting its primary ...
TipRanks on MSN
Boston Scientific’s Vercise™ DBS Study: A Real-World Evaluation of Dystonia Treatment
Boston Scientific (($BSX)) announced an update on their ongoing clinical study. Study Overview: The Vercise™ DBS Dystonia Prospective Study, ...
The US Food and Drug Administration (FDA) has approved a new software upgrade for Abbott's Infinity deep-brain stimulation (DBS) system used in patients with Parkinson's disease and essential tremor, ...
Boston Scientific Corporation BSX has received CE Mark approval for use of the GUIDE™ DBS System, the world's first deep brain stimulation (DBS) visualization system. GUIDE DBS provides clinicians ...
Boston Scientific Corporation BSX recently announced the receipt of the FDA’s approval for its fourth-generation Vercise Genus Deep Brain Stimulation (“DBS”) System. Notably, the DBS portfolio is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback